Hot Biotech Trades for Second-Half 2011

Description:

According to Adam Feuerstein, these biotech trades "encompass pending FDA drug approval decisions and clinical trial results -- all of which have the potential to produce significant stock-price volatility in the next six months." Read more here.

>>Also: 3 Funds' Best Stock Picks Ahead of Earnings

>>Also: 7 Best-Performing Dow Stocks

Most Viewed Portfolios

View All

Articles

5 Short-Squeeze Stocks Set to Soar on Bullish Earnings

09.22.14 | 01:02 PM

DELAFIELD, Wis. (Stockpickr) -- Short-sellers hate being caught short a stock that reports a blowout quarter. When this happens, we often see a tra...

5 Stocks to Trade for Big Breakout Gains

09.22.14 | 11:47 AM

DELAFIELD, Wis. (Stockpickr) -- Trading stocks that trigger major breakouts can lead to massive profits. Once a stock trends to a new high or takes...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter